Amplion
Amplion is an AI-driven intelligence platform designed specifically for life science commercial teams, including pharma, biopharma, and academia. It leverages deep scientific and business data combined with proprietary machine learning to provide targeted marketing, sales, and business development solutions. Amplion helps users identify ideal prospects, monitor actionable events, and discover key contacts, enabling them to optimize lead generation, sales pipelines, and partnership opportunities. The platform integrates with CRM systems to deliver real-time insights and alerts, significantly reducing research time and improving campaign effectiveness. Amplion is positioned as a critical tool for accelerating business growth in the life sciences sector by automating and enhancing lead generation and account targeting processes.
Amplion
Amplion is an AI-driven intelligence platform designed specifically for life science commercial teams, including pharma, biopharma, and academia. It leverages deep scientific and business data combined with proprietary machine learning to provide targeted marketing, sales, and business development solutions. Amplion helps users identify ideal prospects, monitor actionable events, and discover key contacts, enabling them to optimize lead generation, sales pipelines, and partnership opportunities. The platform integrates with CRM systems to deliver real-time insights and alerts, significantly reducing research time and improving campaign effectiveness. Amplion is positioned as a critical tool for accelerating business growth in the life sciences sector by automating and enhancing lead generation and account targeting processes.
TL;DR
Product: AI-driven commercial intelligence platform for life-science sales, marketing, and BD
Founded: February 2013
Acquisition: Assets acquired by Science & Medicine Group (announced Sep 7, 2022)
Series A: Announced Aug 1, 2019; led by Greycroft
Headcount (reported): 3
Company Overview
Problem Domain
Commercial intelligence and lead generation for life-science companies
Founded
2013
Industry
Life sciences / Commercial data & intelligence
Funding Track Record
Series A announced Aug 1, 2019 with participation from Revolution's Rise of the Rest Seed Fund and Imagen Capital Partners; amount undisclosed in press materials.
Investor Signal
“Led by Greycroft with participation from Revolution's Rise of the Rest Seed Fund and Imagen Capital Partners”